C-peptide and Central Nervous System Complications in Diabetes
2004

C-peptide and CNS Complications in Diabetes

publication Evidence: moderate

Author Information

Author(s): Zhen-guo Li, Anders A. F. Sima

Primary Institution: Wayne State University School of Medicine

Hypothesis

The study investigates the role of C-peptide in preventing central nervous system complications associated with diabetes.

Conclusion

C-peptide administration may help prevent neuronal apoptosis and cognitive impairments in type 1 diabetes.

Supporting Evidence

  • C-peptide administration partially corrects the perturbed IGF system in the brain.
  • C-peptide prevents neuronal apoptosis in the hippocampus of type 1 diabetes.
  • Diabetes causes impairments in CNS functions, leading to cognitive deficits.
  • Neuronal apoptosis may play a significant role in cognitive dysfunction in diabetes.

Takeaway

Diabetes can hurt your brain, but a special part of insulin called C-peptide might help protect it.

Methodology

The study reviews clinical and experimental data on CNS complications in diabetes and the effects of C-peptide.

Limitations

The mechanisms of CNS complications in diabetes are not fully understood, and more research is needed.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/15438600490424550

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication